News
June 13, 2019

Researchers and community members discuss data solutions to the opioid crisis

Opioid collaboratory full room

Nearly 100 people gathered at Regenstrief Institute to swap ideas and discuss how to put data to use to solve the growing opioid crisis. Regenstrief leaders also announced a pilot grant program, soliciting ideas to link and utilize the data available through the Indiana Addiction Data Commons (IADC).

The event, called the Opioid Collaboratory, organized by Chris Harle, PhD, M.S., a Regenstrief research scientist, and IADC Program Manager Dan Hood, MPH, included researchers, healthcare providers, health systems leaders, state health leaders and more. In addition to his affiliation with Regenstrief, Dr. Harle is on faculty at Indiana University Richard M. Fairbanks School of Public Health and the IU School of Medicine.

Dr. Embi addresses opioid collaboratory
Regenstrief President and CEO Peter Embí, M.D., M.S., kicked off the meeting, extolling the benefits of partnerships and collaborations to identify solutions to the opioid crisis. He spoke about the importance of bringing datasets together and using them in applied research efforts. His goal is to use the information to rapidly advance research and implement solutions that have impactful results.

Jim McClelland, the executive director for drug prevention, treatment, and enforcement for the State of Indiana also addressed the group. He presented the latest information on Indiana’s efforts to curb the crisis and save the lives of Hoosiers. McClelland spoke about the need for holistic strategies to combat the addiction crisis and the necessity of increasing emphasis on social determinants of health.

Jim McClelland addresses Opioid Collaboratory

Opioid collaboratory participants also got the chance to learn about the specific data available to them through the IADC. The IADC is a collaboration among Regenstrief, the Polis Center, the State Management Performance Hub (MPH) and other organizations, funded by the Indiana University Addictions Grand Challenge. The data commons combines clinical data with information on social determinants of health, such as education and nutrition, offering a framework to expand opioid-related research.

The conference attendees then broke into small groups, where they discussed possible applications of the available data. Ideas included determining risk factors for the stages of opioid use disorder, barriers to successfully completing treatment and the role of mental health. Another suggestion involved using Regenstrief’s nDepth tool to comb through unstructured data, the doctors’ notes in health records, to uncover data that might not be available elsewhere.

Small group breakout at Opioid Collaboratory

Small group break out Opioid collaboratory“These small group discussions really led to some great ideas for how to use this data,” said Hood. “Everyone here has different perspectives on the crisis and what data is useful. Bringing all these perspectives together helps us look with fresh eyes at the problem and its possible solutions.”

The IADC team will use these recommendations to inform its work going forward.

Funding opportunity to utilize IADC

Regenstrief is offering initial funding opportunities for researchers to help unlock the potential of the Indiana Addiction Data Commons. The pilot grant program will enable data collection and integration efforts. Proposals must focus on innovative approaches to integrating unique data sources that can be accessed through the data commons. Awardees will be selected based on potential to advance research focused on the addiction crisis, prospective ability to generate extramural funding, and fit of research questions and approach with current Indiana Addiction Data Commons data sets. Additionally, the awardees will have the opportunity to collaborate with subject matter experts to determine the specific data needs to answer their pressing research queries.

This pilot funding is open to any Indiana University researcher, with strong consideration given to junior faculty. The deadline to submit is August 1, 2019.

Click here to apply for the pilot grant.

This is Regenstrief’s second Opioid Collaboratory meeting. The first was held in 2017, just before the creation of the IADC.

Related News

image of pregnant woman with vaccine acting as protection from COVID virus

National CDC-funded study confirms that mRNA vaccines protect against serious COVID-19 during pregnancy

The first large, real-world study of the effectiveness of mRNA COVID-19 vaccines during pregnancy found these vaccines, especially two

Thomas Imperiale

Journal editorial: Regenstrief researcher calls for tailoring colorectal cancer screening for 45-to-49-year-olds

It’s been a year since national recommendations issued by the American Cancer Society and the U.S. Multi-Society Task Force

Dr. Shaun Grannis on data surveillance of post-COVID conditions

Dr. Shaun Grannis on data surveillance of post-COVID conditions

Regenstrief Vice President for Data and Analytics Shaun Grannis, M.D., M.S., discusses the questions that will be investigated in

Screening tools co-developed by Regenstrief Institute research scientist help clinicians assess and treat vexing symptoms

Screening tools co-developed by Regenstrief Institute research scientist help clinicians assess and treat vexing symptoms

Widely used scales measure pain, depression, anxiety, suicide risk, cancer fatigue and now symptoms associated with a common dental